KnipBio Announces Successful Completion of BioProcessing Feed Scale-Up Program

14Jul

KnipBio Announces Successful Completion of BioProcessing Feed Scale-Up Program

Portfolio News

KnipBio Inc. announces the successful completion of the latest phase in its plan to produce KnipBio Meal, a premium aquaculture feed ingredient from low-cost, readily available feedstocks. The development was done in conjunction with the National Research Council of Canada (NRC). Read more >>

Share this post

Related Posts

05Aug

LaunchPad Medical Rebrands as RevBio and Launches an Updated Website

Executives from LaunchPad Medical, Inc. announced that the company has rebranded. Its new name, RevBio, was chosen since it... read more
26Jan

S’More Launches “3D Profiles” to Enhance Personalization, Interactivity, and Greater Social Discovery

S’More, the world’s first anti-superficial dating app, connecting people based on content instead of headshots, announces the launch of a... read more
30Jun

Wearable Ultrasounds Poised to Revolutionize Healing and Pain Management Healthcare Market

Years ago, George Lewis, Ph.D., founder, President and CEO of ZetrOZ Systems, could see that wearable medical devices were the... read more
02Oct

Eco-friendly Consumer Choices: Small Action, Big Impact

While sustainability can start in your homes, it should be extended far beyond that, says Rahul Singh, Co-founder of EcoSoul... read more
06Mar

Game On for Concussion Therapies

Most concussions—mild traumatic brain injuries (TBIs)—aren’t treated. Only a fraction of people who experience concussions seek help, and those who... read more
02Mar

Startup Q&A – Green Pinata Gives Children A Collection of New Toys Every Month

Green Pinata utilizes the popular monthly subscription box model for parents that are looking to give their children something new... read more
08Aug

How the end of the student loan pause could affect retirement saving

Saving for retirement isn’t going to be a priority for many workers when federal student loan payments resume this fall... read more
22Dec

Endocannabinoid Pathway Targeted Drug Demonstrates Proof-of-Concept Efficacy in a Cutaneous Lupus Erythematosus Mouse Model

Hoth has a partnership agreement with Zylö Therapeutics Inc., to co-develop a new topical treatment for patients with Cutaneous Lupus... read more
02Jun

Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases

Corbus diversifies pipeline with two new mAbs that target integrins that inhibit activation of TGFβ. High potency anti-αvβ8 mAb licensed... read more
05Jan

eSight wants to help 50 million people living with vision loss see by 2020

Toronto-based eSight has launched a pledge to help the 50 million people worldwide living with vision loss and blindness by... read more